Acadian Asset Management
MIRM icon

Acadian Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Acadian Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86K Buy
+743
New +$74.6K ﹤0.01% 1782
2026
Q1 		– Sell
-3,872
Closed -$305K – 2169
2025
Q4 		$305K Buy
+3,872
New +$278K ﹤0.01% 1431
2024
Q4 		– Sell
-1,504
Closed -$58K – 1962
2024
Q3 		$58K Buy
+1,504
New +$60K ﹤0.01% 1756

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management's MIRM Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 743 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #1782 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in MIRM as recently as Q4 2025.

Acadian Asset Management first reported a position in MIRM in Q3 2024 and has held it in 3 quarters since. The position peaked at $305K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Acadian Asset Management held 743 shares of Mirum Pharmaceuticals worth $86K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Acadian Asset Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1782 holding.
  • Acadian Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Acadian Asset Management's Mirum Pharmaceuticals position peaked at $305K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.